Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23
Phase 31

Trial Status

Completed3
Terminated1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT02430077Phase 2Completed
Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients
Familial Partial Lipodystrophy
PrincipalinvestigatorStart date: 2016-06-01
NCT01675154Phase 2Terminated
Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia
Type 1 Hyperlipoproteinemia
PrincipalinvestigatorStart date: 2015-11-01
NCT00457938Not ApplicableCompleted
Novel Therapies for Metabolic Complications of Lipodystrophies
DiabetesHepatic SteatosisHypertriglyceridemia+1 more
Principalinvestigator
NCT00896298Phase 2/3Completed
Trial of Leptin Replacement Therapy in Patients With Lipodystrophy
Generalized LipodystrophyHypoleptinemiaInsulin Resistance+1 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02430077Phase 2PrincipalInvestigator

Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients

Familial Partial Lipodystrophy
Completed
NCT01675154Phase 2PrincipalInvestigator

Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia

Type 1 Hyperlipoproteinemia
Terminated
NCT00457938Not ApplicablePrincipalInvestigator

Novel Therapies for Metabolic Complications of Lipodystrophies

DiabetesHepatic SteatosisHypertriglyceridemia+1 more
Completed
NCT00896298Phase 2/3PrincipalInvestigator

Trial of Leptin Replacement Therapy in Patients With Lipodystrophy

Generalized LipodystrophyHypoleptinemiaInsulin Resistance+1 more
Completed

All 4 trials loaded